Open AccessThis article is
- freely available
Transparency of Reporting in Molecular Diagnostics
Postgraduate Medical Institute, Anglia Ruskin University, Chelmsford CM1 1SQ, UK
Received: 3 July 2013; in revised form: 23 July 2013 / Accepted: 23 July 2013 / Published: 30 July 2013
Abstract: The major advances made over the past few years in molecular and cell biology are providing a progressively more detailed understanding of the molecular pathways that control normal processes and become dysregulated in disease . This has resulted in the documentation of numerous genetic, epigenetic, transcriptomic, proteomic and metabolomic biomarkers that promise earlier disease detection, more accurate patient stratification and better prognosis [2–5]. Furthermore, molecular fingerprinting of diseases can be predictive of drug response and so assist with specific targeting of drugs against disease-associated molecules and function . [...]
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Bustin, S. Transparency of Reporting in Molecular Diagnostics. Int. J. Mol. Sci. 2013, 14, 15878-15884.
Bustin S. Transparency of Reporting in Molecular Diagnostics. International Journal of Molecular Sciences. 2013; 14(8):15878-15884.
Bustin, Stephen. 2013. "Transparency of Reporting in Molecular Diagnostics." Int. J. Mol. Sci. 14, no. 8: 15878-15884.